Aronell has experience in developing drug products used for a wide variety of medical therapies. Primarily, Aronell excels in the formulation development arena of a wide variety of dosage forms. They are especially adept at formulating poorly soluble oral API’s. In general, they have the expertise to help plan and execute a pharmaceutical development plan that will ensure a complete and technically sound CMC section for filing in the US or for worldwide registration. Aronell is committed to providing the highest quality of technical advice to assist their client in selecting the most optimum active pharmaceutical ingredient (API) and developing the most optimized drug delivery system (dosage form) in a timely and cost effective way by minimizing or eliminating development mistakes to shorten the product development path to an approvable NDA CMC section. Aronell can assist you in improving the oral bioavailability (BA) of your drug product. If your current formulation uses micronized API in a tablet or capsule dosage formulation, they guarantee enhanced BA using their expertise and know-how. This increased BA may be essential in ensuring the success of your project by increasing drug plasma levels, providing faster onset of action, or better utilization of drug to lower the dose of an expensive API.